Sunosi (solriamfetol) — Medica
Excessive daytime sleepiness associated with narcolepsy
Preferred products
- modafinil
- armodafinil
Initial criteria
- age ≥ 18 years
- Patient has been evaluated using polysomnography and a multiple sleep latency test
- Diagnosis of narcolepsy has been confirmed by the prescriber
- Medication is prescribed by or in consultation with a sleep specialist physician or a neurologist
- Patient has tried at least ONE of the following treatments: a central nervous system (CNS) stimulant, generic modafinil, or generic armodafinil
- Exception to step therapy is allowed if patient has previously tried brand Provigil or brand Nuvigil
Approval duration
1 year